【Objective】 To investigate the effects and the underlying mechanism of prostaglandin E2 (PGE2) on the proliferation of human CD34+ cells. 【Methods】 Human CD34+ cells were isolated by MACS microbead kits
and the purity was identified by flow cytometry. Then 5×103 /well human CD34+ cells were treated with different concentration dmPGE2. Two hours after cells exposure to ice
erythroid burst forming unit (BFU-E) number and granulocyte monocyte colony forming unit (CFU-GM) number were evaluated by colony-forming assay. Furthermore
cell cycle distribution was analyzed by flow cytometry
and the expression of survivin mRNA
β-catenin and survivin protein of human CD34+ cells was detected by QRT-PCR and Western blot
respectively. 【Results】 The percentage of CD34+ cells in the whole isolated cells was up to 95%. The number of BFU-E and CFU-GM in the 1 μmol/L dmPGE2-treated group was higher than that in the control group and that in the other treatment group (P < 0.05). The proportion of human CD34+ cells which entered into S/G2M phase was 2.18 times of the control group (P < 0.05). The expression level of survivin mRNA
survivin protein andβ-catenin protein was also elevated significantly after exposure to 1 μmol/L dmPGE2. 【Conclusion】 PGE2 promotes human CD34+ cells proliferation. The underlying mechanism was involved in more quiescent CD34+ cells entering into cell division cycle
which was mediated by the elevated survivin and β-catenin after exposure to dmPGE2.
Effect of Exosomes CXCL1 on the Proliferation, Invasion, and Migration of Cervical Cancer Cells
Pancreatic Dysfunction and Influencing Factors of Glucose Metabolism in children with β-thalassemia Major After Allogeneic Hematopoietic Stem Cell Transplantation
METTL3 Regulates the Proliferation, Migration, and Invasion of Uveal Melanoma Cell via Modifying m6A Methylation
Effect of Highly Expressed lysophosphatidyllecithin acyltransferase 4 on Proliferation of Pancreatic Cancer
Related Author
ZHANG Fengmei
ZUO Yanan¹
ZHANG Juncheng¹
HU Qianqian²
LI Hongfang²
DAI Huilian
LIN Shaofen
ZHANG Lina
Related Institution
Department of Obstetrics and Gynecology, The First People’s Hospital of Lanzhou City
The First Clinical Medical School, Gansu University of Chinese Medicine
Department of Pediatrics,Sun Yat-sen Memorial Hospital,Sun Yat-sen University
Department of Ophthalmology,The First Affiliated Hospital of Jinan University
Guangdong Engineering Research Center for Gene Manipulation and Bio-macromolecular Products